BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $55 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Mitchell Kapoor lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $55.00 (from $60.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
